Houston Methodist Hospital/Cancer Center

Houston, Texas 77030

4 studies enrolling now · 11 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Breast Cancer, Biliary Tract Cancer, Breast Cancer, Breast Neoplasms, EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Emotions, HER2- Negative Breast Cancer, Hepatocellular Carcinoma, Hormone Receptor Positive Tumor, Immunology

Studies at this site

• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients — APPROVED_FOR_MARKETING
• CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Stopped early
• Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia — Stopped early
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) — Completed
• Emotions Immunology and Breast Cancer — Completed